This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A double-blind, randomised, placebo controlled, th...
Clinical trial

A double-blind, randomised, placebo controlled, three-period crossover study to investigate the pharmacodynamic effect of two CRF-1 antagonists GSK561679 and GW876008 on meal induced cortisol responses in patients with IBS.

Read time: 1 mins
Last updated:15th May 2007
To determine the pharmacodynamic effect of single doses of GSK561679 and GW876008 on meal induced cortisol responses in patients with IBS.
Category Value
Study start date 2007-05-15

View full details